| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines (2021) | 18.5.1. Insulins | No observations |
| PAHO Strategic Fund Medicine List | 8.2. Insulins and other antidiabetic agents |
Others observations: Limited supply options (normally, none or only one supplier identified / prequalified); may result in longer delivery times. |